Vestor Capital’s Edwards Lifesciences EW Stock Holding History

Vestor Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$235K	Buy	2,940 +1,046	+55%	+$86.2K	0.02%	148
2025 Q4	$251K	Sell	1,894 -1,046	-36%	-$85.8K	0.02%	132
2025 Q3	$229K	Sell	2,940 -65,832	-96%	-$5.14M	0.01%	152
2025 Q2	$2.18M	Buy	68,772 +65,832	+2,239%	+$4.91M	0.16%	78
2025 Q1	$213K	Sell	2,940 -72	-2%	-$5.15K	0.02%	133
2024 Q4	$223K	Buy	3,012 +18	+0.6%	+$1.26K	0.02%	151
2024 Q3	$198K	Buy	2,994 +54	+2%	+$3.92K	0.02%	129
2024 Q2	$272K	Hold	2,940	–	–	0.02%	107
2024 Q1	$281K	Hold	2,940	–	–	0.02%	119
2023 Q4	$224K	Buy	+2,940	New	+$205K	0.02%	119

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vestor Capital's EW Position: Q1 2026 in Review

Vestor Capital increased its Edwards Lifesciences (EW) stake by 55% in Q1 2026, buying an estimated $86.2K and bringing the position to 2,940 shares worth $235K. The position accounts for 0.02% of the portfolio, ranked #148.

Vestor Capital first reported a position in EW in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.18M in Q2 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Vestor Capital held 2,940 shares of Edwards Lifesciences worth $235K as of Q1 2026.
Vestor Capital bought 1,046 Edwards Lifesciences shares in Q1 2026, an estimated $86.2K.
Edwards Lifesciences made up 0.02% of Vestor Capital's portfolio in Q1 2026, its #148 holding.
Vestor Capital first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 10 quarters since.
Vestor Capital's Edwards Lifesciences position peaked at $2.18M in Q2 2025.
1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Vestor Capital's 13F filing for Q1 2026, filed 21 May 2026.